The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies
Open accessAbstract
Immunological tests provide evidence of latent tuberculosis in one third of the global population, which corresponds to more than two billion individuals. Latent tuberculosis is defined by the absence of clinical symptoms but carries a risk of subsequent progression to clinical disease, particularly in the context of co-infection with HIV. In this Review we discuss the biology of latent tuberculosis as part of a broad range of responses that occur following infection with Mycobacterium tuberculosis, which result in the formation of physiologically distinct granulomatous lesions that provide microenvironments with differential ability to support or suppress the persistence of viable bacteria. We then show how this model can be used to develop a rational programme to discover effective drugs for the eradication of M. tuberculosis infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-3-460_4 · Cited by 4,529
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W. D., Siegel, J. N., & Braun, M. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011110 · Cited by 3,710
A Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics
Kohanski, M. A., Dwyer, D. J., Hayete, B., Lawrence, C. A., & Collins, J. J. (2007) · Cell · doi:10.1016/j.cell.2007.06.049 · Cited by 2,982
Genes required for mycobacterial growth defined by high density mutagenesis
Sassetti, C. M., Boyd, D. H., & Rubin, E. J. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03425.x · Cited by 2,544
Drugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
Andries, K., Verhasselt, P., Guillemont, J., Göhlmann, H. W. H., Neefs, J.-M., Winkler, H., Van Gestel, J., Timmerman, P., Zhu, M., Lee, E., et al. (2005) · Science · doi:10.1126/science.1106753 · Cited by 2,191 · cited 1×
“Subsequent identification of the mechanism of action of active compounds is achieved by sequencing the genome of spontaneous drug-resistant mutant”
Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages
Schnappinger, D., Ehrt, S., Voskuil, M. I., Liu, Y., Mangan, J. A., Monahan, I. M., Dolganov, G., Efron, B., Butcher, P. D., Nathan, C., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030846 · Cited by 1,420
Self-citationMcKinney, J. D., zu Bentrup, K. H., Muñoz-Elías, E. J., Miczak, A., Chen, B., Chan, W.-T., Swenson, D., Sacchettini, J. C., Jacobs, W. R., & Russell, D. G. (2000) · Nature · doi:10.1038/35021074 · Cited by 1,360
Genetic requirements for mycobacterial survival during infection
Sassetti, C. M., & Rubin, E. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2134250100 · Cited by 1,354
Systematic Review: T-Cell–based Assays for the Diagnosis of Latent Tuberculosis Infection: An Update
Pai, M., Zwerling, A., & Menzies, D. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-3-200808050-00241 · Cited by 1,339
Inhibition of Respiration by Nitric Oxide Induces a Mycobacterium tuberculosis Dormancy Program
Voskuil, M. I., Schnappinger, D., Visconti, K. C., Harrell, M. I., Dolganov, G. M., Sherman, D. R., & Schoolnik, G. K. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030205 · Cited by 966
Self-citationAntibiotics: Actions, Origins, Resistance
Walsh, C. T. (2003) · Medical Entomology and Zoology · Cited by 675
Tuberculous Granulomas Are Hypoxic in Guinea Pigs, Rabbits, and Nonhuman Primates
Via, L. E., Lin, P. L., Ray, S. M., Carrillo, J., Allen, S. S., Eum, S. Y., Taylor, K., Klein, E., Manjunatha, U., Gonzales, J., et al. (2008) · Infection and Immunity · doi:10.1128/iai.01515-07 · Cited by 664
Self-citationAntibiotics: Actions, Origins, Resistance
Walsh, C. (2003) · Wiley eBooks · doi:10.1128/9781555817886 · Cited by 633
PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release
Singh, R., Manjunatha, U., Boshoff, H. I. M., Ha, Y. H., Niyomrattanakit, P., Ledwidge, R., Dowd, C. S., Lee, I. Y., Kim, P., Zhang, L., et al. (2008) · Science · doi:10.1126/science.1164571 · Cited by 628
Self-citationHill, R. B. (1985) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1985.03350350139038 · Cited by 609
The Transcriptional Responses of Mycobacterium tuberculosis to Inhibitors of Metabolism
Boshoff, H. I. M., Myers, T. G., Copp, B. R., McNeil, M. R., Wilson, M. A., & Barry, C. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406796200 · Cited by 606
Self-citationKohanski, M. A., Dwyer, D. J., Wierzbowski, J., Cottarel, G., & Collins, J. J. (2008) · Cell · doi:10.1016/j.cell.2008.09.038 · Cited by 574
Rao, S. P. S., Alonso, S., Rand, L., Dick, T., & Pethe, K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711697105 · Cited by 517
Self-citationSingle-Cell Microbiology: Tools, Technologies, and Applications
Brehm-Stecher, B. F., & Johnson, E. A. (2004) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.68.3.538-559.2004 · Cited by 501
The Enduring Hypoxic Response of Mycobacterium tuberculosis
Rustad, T. R., Harrell, M. I., Liao, R., & Sherman, D. R. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001502 · Cited by 491
Rodriguez, G. M., Voskuil, M. I., Gold, B., Schoolnik, G. K., & Smith, I. (2002) · Infection and Immunity · doi:10.1128/iai.70.7.3371-3381.2002 · Cited by 490
Capuano, S. V., Croix, D. A., Pawar, S., Zinovik, A., Myers, A., Lin, P. L., Bissel, S., Fuhrman, C., Klein, E., & Flynn, J. L. (2003) · Infection and Immunity · doi:10.1128/iai.71.10.5831-5844.2003 · Cited by 479
Self-citationSonnenberg, P., Glynn, J. R., Fielding, K., Murray, J., Godfrey‐Faussett, P., & Shearer, S. (2005) · The Journal of Infectious Diseases · doi:10.1086/426827 · Cited by 446
Cytological and Transcript Analyses Reveal Fat and Lazy Persister-Like Bacilli in Tuberculous Sputum
Garton, N. J., Waddell, S. J., Sherratt, A. L., Lee, S.-M., Smith, R. J., Senner, C., Hinds, J., Rajakumar, K., Adegbola, R. A., Besra, G. S., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050075 · Cited by 435
Target deconvolution strategies in drug discovery
Terstappen, G. C., Schlüpen, C., Raggiaschi, R., & Gaviraghi, G. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2410 · Cited by 429
Quantitative Comparison of Active and Latent Tuberculosis in the Cynomolgus Macaque Model
Lin, P. L., Rodgers, M., Smith, L., Bigbee, M., Myers, A., Bigbee, C., Chiosea, I., Capuano, S. V., Fuhrman, C., Klein, E., et al. (2009) · Infection and Immunity · doi:10.1128/iai.00592-09 · Cited by 425
Self-citationThe Structure of a Mycobacterial Outer-Membrane Channel
Faller, M., Niederweis, M., & Schulz, G. E. (2004) · Science · doi:10.1126/science.1094114 · Cited by 421
Rohde, K. H., Abramovitch, R. B., & Russell, D. G. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2007.09.006 · Cited by 405
Muñoz‐Elías, E. J., Upton, A. M., Cherian, J., & McKinney, J. D. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05155.x · Cited by 359
Pulmonary Tuberculoma Evaluated by Means of FDG PET: Findings in 10 Cases
Goo, J. M., Im, J.-G., Do, K.-H., Yeo, J. S., Seo, J. B., Kim, H. Y., & Chung, J.-K. (2000) · Radiology · doi:10.1148/radiology.216.1.r00jl19117 · Cited by 354
Microbial phenotypic heterogeneity and antibiotic tolerance
Dhar, N., & McKinney, J. D. (2007) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.12.007 · Cited by 333
Manjunatha, U. H., Boshoff, H., Dowd, C. S., Zhang, L., Albert, T. J., Norton, J. E., Daniels, L., Dick, T., Pang, S. S., & Barry, C. E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508392103 · Cited by 331
Self-citationMulti-targeting by monotherapeutic antibacterials
Silver, L. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2202 · Cited by 311
Fisher, M. A., Plikaytis, B. B., & Shinnick, T. M. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.14.4025-4032.2002 · Cited by 309
Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis
Wayne, L. G., & Sramek, H. A. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.9.2054 · Cited by 295
Mycolic Acid Structure Determines the Fluidity of the Mycobacterial Cell Wall
Liu, J., Barry, C. E., Besra, G. S., & Nikaido, H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.47.29545 · Cited by 288
Self-citationTimm, J., Post, F. A., Bekker, L.-G., Walther, G. B., Wainwright, H. C., Manganelli, R., Chan, W.-T., Tsenova, L., Gold, B., Smith, I., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2436197100 · Cited by 279
Rhoades, E. R., Frank, A. A., & Orme, I. M. (1997) · Tubercle and Lung Disease · doi:10.1016/s0962-8479(97)90016-2 · Cited by 277
BIOCHEMICAL DIFFERENTIATION OF MYCOBACTERIUM TUBERCULOSIS GROWN IN VIVO AND IN VITRO
Segal, W., & Bloch, H. (1956) · Journal of Bacteriology · doi:10.1128/jb.72.2.132-141.1956 · Cited by 272
Tsenova, L., Ellison, E., Harbacheuski, R., Moreira, A. L., Kurepina, N., Reed, M. B., Mathema, B., Barry III, C. E., & Kaplan, G. (2005) · The Journal of Infectious Diseases · doi:10.1086/430614 · Cited by 264
The mycobacteria: a sourcebook
Grange, J. M. (1985) · Tubercle · doi:10.1016/0041-3879(85)90041-8 · Cited by 258
Gandotra, S., Schnappinger, D., Monteleone, M., Hillen, W., & Ehrt, S. (2007) · Nature Medicine · doi:10.1038/nm1683 · Cited by 254
Self-citationUnique Transcriptome Signature of Mycobacterium tuberculosis in Pulmonary Tuberculosis
Rachman, H., Strong, M., Ulrichs, T., Grode, L., Schuchhardt, J., Mollenkopf, H., Kosmiadi, G. A., Eisenberg, D., & Kaufmann, S. H. E. (2006) · Infection and Immunity · doi:10.1128/iai.74.2.1233-1242.2006 · Cited by 243
Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies.
Comstock, G. W., Baum, C., & Snider, D. E. (1979) · PubMed · doi:10.1164/arrd.1979.119.5.827 · Cited by 241
Early Events in Mycobacterium tuberculosis Infection in Cynomolgus Macaques
Lin, P. L., Pawar, S., Myers, A., Pegu, A., Fuhrman, C., Reinhart, T. A., Capuano, S. V., Klein, E., & Flynn, J. L. (2006) · Infection and Immunity · doi:10.1128/iai.00064-06 · Cited by 233
Self-citationBiomarkers for tuberculosis disease activity, cure, and relapse
Wallis, R. S., Doherty, T. M., Onyebujoh, P., Vahedi, M., Laang, H., Olesen, O., Parida, S., & Zumla, A. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70042-8 · Cited by 222
Eliminating latent tuberculosis
Young, D. B., Gideon, H. P., & Wilkinson, R. J. (2009) · Trends in Microbiology · doi:10.1016/j.tim.2009.02.005 · Cited by 220
Self-citationDynamic Antigen-specific T-Cell Responses after Point-Source Exposure to Mycobacterium tuberculosis
Ewer, K., Millington, K. A., Deeks, J. J., Alvarez, L., Bryant, G., & Lalvani, A. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200511-1783oc · Cited by 214
GSMN-TB: a web-based genome-scale network model of Mycobacterium tuberculosismetabolism
Beste, D. J., Hooper, T., Stewart, G., Bonde, B., Avignone-Rossa, C., Bushell, M. E., Wheeler, P., Klamt, S., Kierzek, A. M., & McFadden, J. (2007) · Genome Biology · doi:10.1186/gb-2007-8-5-r89 · Cited by 207
Tailleux, L., Waddell, S. J., Pelizzola, M., Mortellaro, A., Withers, M., Tanne, A., Castagnoli, P. R., Gicquel, B., Stoker, N. G., Butcher, P. D., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001403 · Cited by 195
Mtei, L., Matee, M., Herfort, O., Bakari, M., Horsburgh, C. R., Waddell, R., Cole, B. F., Vuola, J. M., Tvaroha, S., Kreiswirth, B., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/429825 · Cited by 189
Ferebee, S. H., & MOUNT, F. W. (1962) · PubMed · doi:10.1164/arrd.1962.85.4.490 · Cited by 187
Fenhalls, G., Stevens, L., Moses, L., Bezuidenhout, J., Betts, J. C., Helden, P. V., Lukey, P. T., & Duncan, K. (2002) · Infection and Immunity · doi:10.1128/iai.70.11.6330-6338.2002 · Cited by 161
Biosynthesis and Recycling of Nicotinamide Cofactors in Mycobacterium tuberculosis
Boshoff, H. I. M., Xu, X., Tahlan, K., Dowd, C. S., Pethe, K., Camacho, L. R., Park, T.-H., Yun, C.-S., Schnappinger, D., Ehrt, S., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800694200 · Cited by 159
Self-citationUptake Rates of 18F-Fluorodeoxyglucose and 11C-Choline in Lung Cancer and Pulmonary Tuberculosis
Hara, T., Kosaka, N., Suzuki, T., Kudo, K., & Niino, H. (2003) · CHEST Journal · doi:10.1378/chest.124.3.893 · Cited by 152
Converse, P. J., Karakousis, P. C., Klinkenberg, L. G., Kesavan, A. K., Ly, L. H., Allen, S. S., Grosset, J. H. E., Jain, S. K., Lamichhane, G., Manabe, Y. C., et al. (2008) · Infection and Immunity · doi:10.1128/iai.01117-08 · Cited by 152
Contribution of CD8+ T Cells to Control of Mycobacterium tuberculosis Infection
Sud, D., Bigbee, C., Flynn, J. L., & Kirschner, D. E. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.4296 · Cited by 152
Self-citationRay, J. C. J., Flynn, J. L., & Kirschner, D. E. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802297 · Cited by 149
Self-citationFlux Balance Analysis of Mycolic Acid Pathway: Targets for Anti-Tubercular Drugs
Raman, K., Rajagopalan, P., & Chandra, N. R. (2005) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0010046 · Cited by 149
Differential Antibiotic Susceptibilities of Starved Mycobacterium tuberculosis Isolates
Xie, Z., Siddiqi, N., & Rubin, E. J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4778-4780.2005 · Cited by 136
Malhotra, V., Sharma, D., Ramanathan, V. D., Shakila, H., Saini, D. K., Chakravorty, S., Das, T. K., Li, Q., Silver, R. F., Narayanan, P. R., et al. (2004) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(04)00002-3 · Cited by 120
The Mycobacteria : a sourcebook
Kubica, G. P., & Wayne, L. G. (1984) · Marcel Dekker eBooks · Cited by 119
Wilkinson, K. A., Kon, O. M., Newton, S. M., Meintjes, G., Davidson, R. N., Pasvol, G., & Wilkinson, R. J. (2006) · The Journal of Infectious Diseases · doi:10.1086/499311 · Cited by 119
Self-citationThe aerosol rabbit model of TB latency, reactivation and immune reconstitution inflammatory syndrome
Manabe, Y. C., Kesavan, A. K., Lopez-Molina, J., Hatem, C. L., Brooks, M. E., Fujiwara, R. T., Hochstein, K., Pitt, M. L. M., Tufariello, J. M., Chan, J., et al. (2007) · Tuberculosis · doi:10.1016/j.tube.2007.10.006 · Cited by 114
Fragment-based approaches to enzyme inhibition
Ciulli, A., & Abell, C. (2007) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2007.09.003 · Cited by 109
Pathogenesis of Human Pulmonary Tuberculosis
Dannenberg, A. M. (2006) · ASM Press eBooks · doi:10.1128/9781555815684 · Cited by 108
The Targets of Currently Used Antibacterial Agents: Lessons for Drug Discovery
Lange, R., Locher, H. H., Wyss, P. C., et al. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207782110408 · Cited by 107
Talaat, A. M., Ward, S. K., Wu, C., Rondon, E., Tavano, C. L., Bannantine, J. P., Lyons, R., & Johnston, S. A. (2007) · Journal of Bacteriology · doi:10.1128/jb.00011-07 · Cited by 98
Improved tetracycline repressors for gene silencing in mycobacteria
Klotzsche, M., Ehrt, S., & Schnappinger, D. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp015 · Cited by 94
Self-citationA controlled trial of isoniazid prophylaxis in mental institutions
Ferebee, S. H., MOUNT, F. W., Murray, F. J., & Livesay, V. T. (1964) · Nursing Research · doi:10.1097/00006199-196401320-00046 · Cited by 91
Paramasivan, C. N., Sulochana, S., Kubendiran, G., Venkatesan, P., & Mitchison, D. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.627-631.2005 · Cited by 91
Permeability of the mycobacterial cell wall
Nikaido, H., & Jarlier, V. (1991) · Research in Microbiology · doi:10.1016/0923-2508(91)90117-s · Cited by 90
Herbert, D., Paramasivan, C. N., Venkatesan, P., Kubendiran, G., Prabhakar, R., & Mitchison, D. A. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.10.2296 · Cited by 86
THE TREATED PULMONARY LESION AND ITS TUBERCLE BACILLUS.*
Vandiviere, H. M., LORING, W. E., Melvin, I. G., & Willis, S. (1956) · The American Journal of the Medical Sciences · doi:10.1097/00000441-195607000-00006 · Cited by 72
The relA Homolog of Mycobacterium smegmatis Affects Cell Appearance, Viability, and Gene Expression
Dahl, J. L., Arora, K., Boshoff, H. I., Whiteford, D. C., Pacheco, S. A., Walsh, O. J., Lau-Bonilla, D., Davis, W. B., & Garza, A. G. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.7.2439-2447.2005 · Cited by 65
Self-citationGoletti, D., Parracino, M. P., Butera, O., Bizzoni, F., Casetti, R., Dainotto, D., Anzidei, G., Nisii, C., Ippolito, G., Poccia, F., et al. (2007) · Respiratory Research · doi:10.1186/1465-9921-8-5 · Cited by 61
Evaluation of Therapeutic Response of Tuberculoma Using F-18 FDG Positron Emission Tomography
Park, I.-N., Ryu, J., & Shim, T. S. (2008) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e31815c5128 · Cited by 60
Intense uptake of [F-18]-fluoro-2 deoxy-d-glucose in active pulmonary tuberculosis
Yang, C.-M., Hsu, C., Lee, C., & Wang, F.-C. (2003) · Annals of Nuclear Medicine · doi:10.1007/bf03006610 · Cited by 51
Tuberculosis genes expressed during persistence and reactivation in the resistant rabbit model
Kesavan, A. K., Brooks, M. E., Tufariello, J. M., Chan, J., & Manabe, Y. C. (2008) · Tuberculosis · doi:10.1016/j.tube.2008.08.004 · Cited by 50
Gj, V. (1968) · PubMed · Cited by 46
Radaeva, T. V., Nikonenko, B. V., Mischenko, V. V., Averbakh, M. M., & Apt, A. S. (2005) · Tuberculosis · doi:10.1016/j.tube.2004.09.014 · Cited by 36
Pathogenic and immunogenic differentiation of Mycobacterium tuberculosis grown in vitro and in vivo.
Segal, A. W., & Blöch, H. (1957) · PubMed · doi:10.1164/artpd.1957.75.3.495 · Cited by 26
Tuberculosis Drug Discovery: Issues, Gaps and the Way Forward
Dartois, V. A., Leong, F. J., & Dick, T. (2009) · Wiley eBooks · doi:10.1002/9783527626816.ch21 · Cited by 10
Self-citation
Cited by
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., Wilkinson, K. A., Banchereau, R., Skinner, J., Wilkinson, R. J., et al. (2010) · Nature · doi:10.1038/nature09247 · Cited by 1,898
Self-citationLewis, K. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134306 · Cited by 1,858
The Immune Response in Tuberculosis
O'Garra, A., Redford, P. S., McNab, F. W., Bloom, C. I., Wilkinson, R. J., & Berry, M. P. R. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095939 · Cited by 1,342
Self-citationPai, M., Behr, M. A., Dowdy, D., Dheda, K., Divangahi, M., Boehme, C. C., Ginsberg, A., Swaminathan, S., Spigelman, M., Getahun, H., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.76 · Cited by 1,270
The challenge of new drug discovery for tuberculosis
Koul, A., Arnoult, E., Lounis, N., Guillemont, J., & Andries, K. (2011) · Nature · doi:10.1038/nature09657 · Cited by 1,042
Metadata
- Authors
- Barry, C. E., Boshoff, H. I., Dartois, V., Dick, T., Ehrt, S., Flynn, J., Schnappinger, D., Wilkinson, R. J., & Young, D.
- Venue
- Nature Reviews Microbiology
- Published
- 2009-10-26
- Volume
- 7
- Issue
- 12
- Pages
- 845-855
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- OpenAlex
- W1969623044
- Cited by
- 1,422
- References
- 84
- FWCI
- 7.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.